Wei Wang

Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma

S. Horvath, T. Cloughesy, L. Liau, 2008, PLoS medicine.

Inducing and exploiting vulnerabilities for the treatment of liver cancer

R. Bernards, R. Beijersbergen, S. Mainardi, 2019, Nature.

PTPRC promoted CD8+ T cell mediated tumor immunity and drug sensitivity in breast cancer: based on pan-cancer analysis and artificial intelligence modeling of immunogenic cell death-based drug sensitivity stratification

Pengping Li, Guodong Cao, Tonghe Pan, 2023, Frontiers in Immunology.